What question did this study set out to answer?

This research aims to evaluate the challenges of controlling pharmaceutical expenditures in Spain.

Pharmaceutical Expenditure in Spain: Cost and Control

View Full Paper

Ask AI

Bookmark

This research aims to evaluate the challenges of controlling pharmaceutical expenditures in Spain.
Analysis of price changes for pharmaceutical products over 15 years
Examination of government interventions to control costs
Evaluation of the impact of new drug introductions on expenditure
Pharmaceutical expenditures increased by 264% over 15 years despite a 39% decline in old product prices.
Consumption in value rose by only 10%, indicating poor cost control effectiveness.
The rise in expenditures is largely driven by the introduction of new, expensive drugs with limited therapeutic benefits.

No takes yet. Share an insight, caveat, or question.

Analyzed cost-control measures and expenditure trends in Spain, revealing a rise despite price reductions.

Bastida et al. (2000) studied this question.

View Full Paper

Ask AI

Bookmark